mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.1 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.1 |
mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.1 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.1 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |